Function and potentials of M. tuberculosis epitopes

Frontiers in Immunology

Volumn 5, Issue MAR, 2014, Pages

  Ivanyi, Juraj ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antigenic structure; Epitope mapping; Immunodiagnosis; Immunodominant epitopes; Immunopathogenesis; Immunotherapy; Tuberculosis

Indexed keywords

CRYSTALLIN; DNA; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY SPECIFICITY; ATYPICAL MYCOBACTERIUM; AUTOIMMUNITY; CELL FUNCTION; CROSS ALLERGY; CROSS REACTION; DISEASE CONTROL; DNA SEQUENCE; EPITOPE MAPPING; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFECTION; MAJOR HISTOCOMPATIBILITY COMPLEX; MYCOBACTERIUM TUBERCULOSIS; PROTEIN EXPRESSION; REVIEW; SERODIAGNOSIS; TUBERCULOSIS;

EID: 84897947550     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00107     Document Type: Review

References (145)

1. Ivanyi J. Pathogenic and protective interactions in mycobacterial infections. Clin Immunol (1986) 6:127-57.
2. Ivanyi J, Morris JA, Keen M. Studies with monoclonal antibodies to mycobacteria. In: Macario AJL, Macario EC, editors. Monoclonal Antibodies Against Bacteria. New York: Academic Press (1985). p. 59-90.
3. Ivanyi J, Sharp K, Jackett P, Bothamley G. Immunological study of the defined constituents of mycobacteria. Springer Semin Immunopathol (1988) 10:279-300. doi: 10.1007/BF02053841
4. Young RA, Bloom BR, Grosskinsky CM, Ivanyi J, Thomas D, Davis RW. Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc Natl Acad Sci U S A (1985) 82:2583-7. doi:10.1073/pnas.82.9.2583
5. Lamb JR, Ivanyi J, Rees AD, Rothbard JB, Howland K, Young RA, et al. Mapping of T cell epitopes using recombinant antigens and synthetic peptides. EMBO J (1987) 6:1245-9.
6. McMurry JA, Kimball S, Lee JH, Rivera D, Martin W, Weiner DB, et al. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice. Curr Mol Med (2007) 7:351-68. doi:10.2174/156652407780831584
7. Vordermeier M, Whelan AO, Hewinson RG. Recognition of mycobacterial epitopes by T cells across mammalian species and use of a program that predicts human HLA-DR binding peptides to predict bovine epitopes. Infect Immun (2003) 71:1980-7. doi:10.1128/IAI.71.4.1980-1987.2003
8. Scarabelli G, Morra G, Colombo G. Predicting interaction sites from the energetics of isolated proteins: a new approach to epitope mapping. Biophys J (2010) 98:1966-75. doi:10.1016/j.bpj.2010.01.014
9. Berry MP, Blankley S, Graham CM, Bloom CI, O'Garra A. Systems approaches to studying the immune response in tuberculosis. Curr Opin Immunol (2013) 25:579-87. doi:10.1016/j.coi.2013.08.003
10. Ernst JD, Lewinsohn DM, Behar S, Blythe M, Schlesinger LS, Kornfeld H, et al. Meeting report: NIH workshop on the tuberculosis immune epitope database. Tuberculosis (Edinb) (2008) 88:366-70. doi:10.1016/j.tube.2007.11.002
11. Lindestam Arlehamn CS, Gerasimova A, Mele F, Henderson R, Swann J, Greenbaum JA, et al. Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset. PLoS Pathog (2013) 9:e1003130. doi:10.1371/journal.ppat.1003130
12. Axelsson-Robertson R, Magalhaes I, Parida SK, Zumla A, Maeurer M. The immunological footprint of Mycobacterium tuberculosis T-cell epitope recognition. J Infect Dis (2012) 205(Suppl 2):S301-15. doi:10.1093/infdis/jis198
13. Brett SJ, Lamb JR, Cox JH, Rothbard JB, Mehlert A, Ivanyi J. Differential pattern of T cell recognition of the 65-kDa mycobacterial antigen following immunization with the whole protein or peptides. Eur J Immunol (1989) 19:1303-10. doi:10.1002/eji.1830190723
14. Vordemeier HM, Harris DP, Roman E, Lathigra R, Moreno C, Ivanyi J. Identification of T cell stimulatory peptides from the 38-kDa protein of Mycobacterium tuberculosis. J Immunol (1991) 147:1023-9.
15. Harris DP, Vordermeier HM, Friscia G, Roman E, Surcel HM, Pasvol G, et al. Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cells. J Immunol (1993) 150:5041-50.
16. Vordermeier HM, Harris DP, Lathigra R, Roman E, Moreno C, Ivanyi J. Recognition of peptide epitopes of the 16,000 MW antigen of Mycobacterium tuberculosis by murine T cells. Immunology (1993) 80:6-12.
17. Vordermeier HM, Arya A, Harris DP, Moreno C, Ivanyi J. Abundance of H-2 promiscuous T cells specific for mycobacterial determinants in H-2b/d F1 hybrid mice. Eur J Immunol (1995) 25:2770-4. doi:10.1002/eji.1830251009
18. Harris DP, Vordermeier HM, Arya A, Moreno C, Ivanyi J. Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules. Immunology (1995) 84:555-61.
19. Roman E, Harris DP, Jurcevic S, Ivanyi J, Moreno C. H-2-associated effects of flanking residues on the recognition of a permissive mycobacterial T-cell epitope. Immunology (1995) 86:183-9.
20. Agrewala JN, Wilkinson RJ. Influence of HLA-DR on the phenotype of CD4+ T lymphocytes specific for an epitope of the 16-kDa alpha-crystallin antigen of Mycobacterium tuberculosis. Eur J Immunol (1999) 29:1753-61. doi:10.1002/(SICI)1521-4141(199906)29:06<753::AID-IMMU1753>3.0.CO;2-B
21. Comas I, Chakravartti J, Small PM, Galagan J, Niemann S, Kremer K, et al. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet (2010) 42:498-503. doi:10.1038/ng.590
22. Jurcevic S, Hills A, Pasvol G, Davidson RN, Ivanyi J, Wilkinson RJ. T cell responses to a mixture of Mycobacterium tuberculosis peptides with complementary HLA-DR binding profiles. Clin Exp Immunol (1996) 105:416-21. doi:10.1046/j.1365-2249.1996.d01-791.x
23. Mustafa AS, Lundin KE, Meloen RH, Shinnick TM, Oftung F. Identification of promiscuous epitopes from the mycobacterial 65-kilodalton heat shock protein recognized by human CD4(+) T cells of the Mycobacterium leprae memory repertoire. Infect Immun (1999) 67:5683-9.
24. Chua-Intra B, Peerapakorn S, Davey N, Jurcevic S, Busson M, Vordermeier HM, et al. T-cell recognition of mycobacterial GroES peptides in Thai leprosy patients and contacts. Infect Immun (1998) 66:4903-9.
25. Caccamo N, Barera A, Di Sano C, Meraviglia S, Ivanyi J, Hudecz F, et al. Cytokine profile, HLA restriction and TCR sequence analysis of human CD4+ T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein. Clin Exp Immunol (2003) 133:260-6. doi:10.1046/j.1365-2249.2003.02201.x
26. Shams H, Klucar P, Weis SE, Lalvani A, Moonan PK, Safi H, et al. Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles. J Immunol (2004) 173:1966-77.
27. Tully G, Kortsik C, Hohn H, Zehbe I, Hitzler WE, Neukirch C, et al. Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection. J Immunol (2005) 174:2174-84.
28. Valle MT, Megiovanni AM, Merlo A, Li Pira G, Bottone L, Angelini G, et al. Epitope focus, clonal composition and Th1 phenotype of the human CD4 response to the secretory mycobacterial antigen Ag85. Clin Exp Immunol (2001) 123:226-32. doi:10.1046/j.1365-2249.2001.01450.x
29. Al-Attiyah R, Shaban FA, Wiker HG, Oftung F, Mustafa AS. Synthetic peptides identify promiscuous human Th1 cell epitopes of the secreted mycobacterial antigen MPB70. Infect Immun (2003) 71:1953-60. doi:10.1128/IAI.71.4.1953-1960.2003
30. Wang M, Tang ST, Stryhn A, Justesen S, Larsen MV, Dziegiel MH, et al. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides. Immunology (2011) 132:482-91. doi:10.1111/j.1365-2567.2010.03383.x
31. Vordermeier HM, Harris DP, Friscia G, Roman E, Surcel HM, Moreno C, et al. T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease. Eur J Immunol (1992) 22:2631-7. doi:10.1002/eji.1830221024
32. Friscia G, Vordermeier HM, Pasvol G, Harris DP, Moreno C, Ivanyi J. Human T cell responses to peptide epitopes of the 16-kD antigen in tuberculosis. Clin Exp Immunol (1995) 102:53-7. doi:10.1111/j.1365-2249.1995.tb06635.x
33. Weichold FF, Mueller S, Kortsik C, Hitzler WE, Wulf MJ, Hone DM, et al. Impact of MHC class I alleles on the M. tuberculosis antigen-specific CD8+ T-cell response in patients with pulmonary tuberculosis. Genes Immun (2007) 8:334-43. doi:10.1038/sj.gene.6364392
34. Axelsson-Robertson R, Weichold F, Sizemore D, Wulf M, Skeiky YA, Sadoff J, et al. Extensive major histocompatibility complex class I binding promiscuity for Mycobacterium tuberculosis TB10.4 peptides and immune dominance of human leucocyte antigen (HLA)-B*0702 and HLA-B*0801 alleles in TB10.4 CD8 T-cell responses. Immunology (2010) 129:496-505. doi:10.1111/j.1365-2567.2009.03201.x
35. Jurcevic S, Travers PJ, Hills A, Agrewala JN, Moreno C, Ivanyi J. Distinct conformations of a peptide bound to HLA-DR1 or DRB5*0101 suggested by molecular modelling. Int Immunol (1996) 8:1807-14. doi:10.1093/intimm/8.11.1807
36. Caccamo N, Meraviglia S, La Mendola C, Bosze S, Hudecz F, Ivanyi J, et al. Characterization of HLA-DR-and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis. Eur J Immunol (2004) 34:2220-9. doi:10.1002/eji.200425090
37. Sundaramurthi JC, Brindha S, Shobitha SR, Swathi A, Ramanandan P, Hanna LE. In silico identification of potential antigenic proteins and promiscuous CTL epitopes in Mycobacterium tuberculosis. Infect Genet Evol (2012) 12:1312-8. doi:10.1016/j.meegid.2012.03.023
38. Bobosha K, Tang ST, van der Ploeg-van Schip JJ, Bekele Y, Martins MV, Lund O, et al. Mycobacterium leprae virulence-associated peptides are indicators of exposure to M. leprae in Brazil, Ethiopia and Nepal. Mem Inst Oswaldo Cruz (2012) 107(Suppl 1):112-23. doi:10.1590/S0074-02762012000900018
39. Wiens KE, Swaminathan H, Copin R, Lun DS, Ernst JD. Equivalent T cell epitope promiscuity in ecologically diverse human pathogens. PLoS One (2013) 8:e73124. doi:10.1371/journal.pone.0073124
40. Ivanyi J, Norton PM, Matsuzaki G. Immune responses to stress proteins in mycobacterial infections. In: van Eden W, Young DB, editors. Stress Proteins in Medicine. New York: Marcel Dekker, Inc. (1996). p. 265-285.
41. Kiessling R, Gronberg A, Ivanyi J, Soderstrom K, Ferm M, Kleinau S, et al. Role of hsp60 during autoimmune and bacterial inflammation. Immunol Rev (1991) 121:91-111. doi:10.1111/j.1600-065X.1991.tb00824.x
42. Wick G, Kleindienst R, Schett G, Amberger A, Xu Q. Role of heat shock protein 65/60 in the pathogenesis of atherosclerosis. Int Arch Allergy Immunol (1995) 107:130-1. doi:10.1159/000236952
43. Van Eden W, Wick G, Albani S, Cohen I. Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Ann N Y Acad Sci (2007) 1113:217-37. doi:10.1196/annals.1391.020
44. Grundtman C, Kreutmayer SB, Almanzar G, Wick MC, Wick G. Heat shock protein 60 and immune inflammatory responses in atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 31:960-8. doi:10.1161/ATVBAHA.110.217877
45. Raine CS, Wu E, Ivanyi J, Katz D, Brosnan CF. Multiple sclerosis: a protective or a pathogenic role for heat shock protein 60 in the central nervous system? Lab Invest (1996) 75:109-23.
46. Spencer JS, Marques MA, Lima MC, Junqueira-Kipnis AP, Gregory BC, Truman RW, et al. Antigenic specificity of the Mycobacterium leprae homologue of ESAT-6. Infect Immun (2002) 70:1010-3. doi:10.1128/IAI.70.2.1010-1013.2002
47. Ivanyi J. Recall of antibody synthesis to the primary antigen following successive immunization with heterologous albumins. A two-cell theory of the original antigenic sin. Eur J Immunol (1972) 2:354-9. doi:10.1002/eji.1830020411
48. Bothamley G, Beck JS, Britton W, Elsaghier A, Ivanyi J. Antibodies to Mycobacterium tuberculosis-specific epitopes in lepromatous leprosy. Clin Exp Immunol (1991) 86:426-32. doi:10.1111/j.1365-2249.1991.tb02948.x
49. Harris DP, Vordermeier HM, Singh M, Moreno C, Jurcevic S, Ivanyi J. Cross-recognition by T cells of an epitope shared by two unrelated mycobacterial antigens. Eur J Immunol (1995) 25:3173-9. doi:10.1002/eji.1830251128
50. Harris DP, Vordermeier HM, Roman E, Lathigra R, Brett SJ, Moreno C, et al. Murine T cell-stimulatory peptides from the 19-kDa antigen of Mycobacterium tuberculosis. Epitope-restricted homology with the 28-kDa protein of Mycobacterium leprae. J Immunol (1991) 147:2706-12.
51. Jackett PS, Bothamley GH, Batra HV, Mistry A, Young DB, Ivanyi J. Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis. J Clin Microbiol (1988) 26:2313-8.
52. Elsaghier A, Lathigra R, Ivanyi J. Localisation of linear epitopes at the carboxy-terminal end of the mycobacterial 71 kDa heat shock protein. Mol Immunol (1992) 29:1153-6. doi:10.1016/0161-5890(92)90049-4
53. Elsaghier A, Prantera C, Bothamley G, Wilkins E, Jindal S, Ivanyi J. Disease association of antibodies to human and mycobacterial hsp70 and hsp60 stress proteins. Clin Exp Immunol (1992) 89:305-9. doi:10.1111/j.1365-2249.1992.tb06950.x
54. Elsaghier A, Prantera C, Moreno C, Ivanyi J. Antibodies to Mycobacterium paratuberculosis-specific protein antigens in Crohn's disease. Clin Exp Immunol (1992) 90:503-8. doi:10.1111/j.1365-2249.1992.tb05874.x
55. Chua-Intra B, Ivanyi J, Hills A, Thole J, Moreno C, Vordermeier HM. Predominant recognition of species-specific determinants of the GroES homologues from Mycobacterium leprae and M. tuberculosis. Immunology (1998) 93:64-72. doi:10.1046/j.1365-2567.1998.00400.x
56. Chua-Intra B, Wilkinson RJ, Ivanyi J. Selective T-cell recognition of the N-terminal peptide of GroES in tuberculosis. Infect Immun (2002) 70:1645-7. doi:10.1128/IAI.70.3.1645-1647.2002
57. Chua-Intra B, Wattanapokayakit S, Srisungngam S, Srisungngam T, Mahotarn K, Brennan PJ, et al. T-cell recognition of peptides from the Mycobacterium leprae 35 kDa protein in Thai leprosy patients, healthy contacts, and non-contacts. Immunol Lett (2003) 88:71-6. doi:10.1016/S0165-2478(03)00065-8
58. Kaleab B, Wondimu A, Likassa R, Woldehawariat N, Ivanyi J. Sustained T-cell reactivity to Mycobacterium tuberculosis specific antigens in "split-anergic" leprosy. Lepr Rev (1995) 66:19-25.
59. Praputpittaya K, Ivanyi J. Stimulation by anti-idiotype antibody of murine T cell responses to the 38 kD antigen of Mycobacterium tuberculosis. Clin Exp Immunol (1987) 70:307-15.
60. Rees AD, Scoging A, Dobson N, Praputpittaya K, Young D, Ivanyi J, et al. T cell activation by anti-idiotypic antibody: mechanism of interaction with antigen-reactive T cells. Eur J Immunol (1987) 17:197-201. doi:10.1002/eji.1830170208
61. Mackworth-Young CG, Cairns E, Sabbaga J, Massicotte H, Diamond B, Bell DA, et al. Comparative study of idiotypes on monoclonal antibodies derived from patients with lupus and leprosy and from normal individuals. J Autoimmun (1990) 3:415-29. doi:10.1016/S0896-8411(05)80009-5
62. Zumla A, Williams W, Mudd D, Locniskar M, Behrens R, Isenberg D, et al. Expression of a common idiotype PR4 in the sera of patients with leprosy. Clin Exp Immunol (1991) 84:522-6.
63. Arlehamn CS, Sidney J, Henderson R, Greenbaum JA, James EA, Moutaftsi M, et al. Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ). J Immunol (2012) 188:5020-31. doi:10.4049/jimmunol.1103556
64. Flores-Villalva S, Suarez-Guemes F, Espitia C, Whelan AO, Vordermeier M, Gutierrez-Pabello JA. Specificity of the tuberculin skin test is modified by use of a protein cocktail containing ESAT-6 and CFP-10 in cattle naturally infected with Mycobacterium bovis. Clin Vaccine Immunol (2012) 19:797-803. doi:10.1128/CVI.05668-11
65. Casal C, Bezos J, Diez-Guerrier A, Alvarez J, Romero B, de Juan L, et al. Evaluation of two cocktails containing ESAT-6, CFP-10 and Rv-3615c in the intradermal test and the interferon-gamma assay for diagnosis of bovine tuberculosis. Prev Vet Med (2012) 105:149-54. doi:10.1016/j.prevetmed.2012.02.007
66. Saleem IY, Vordermeier M, Barralet JE, Coombes AG. Improving peptide-based assays to differentiate between vaccination and Mycobacterium bovis infection in cattle using nanoparticle carriers for adsorbed antigens. J Control Release (2005) 102:551-61. doi:10.1016/j.jconrel.2004.10.034
67. Ruhwald M, Aabye MG, Ravn P. IP-10 release assays in the diagnosis of tuberculosis infection: current status and future directions. Expert Rev Mol Diagn (2012) 12:175-87. doi:10.1586/erm.11.97
68. Aabye MG, Latorre I, Diaz J, Maldonado J, Mialdea I, Eugen-Olsen J, et al. Dried plasma spots in the diagnosis of tuberculosis: IP-10 release assay on filter paper. Eur Respir J (2013) 42:495-503. doi:10.1183/09031936.00129412
69. Uplekar S, Heym B, Friocourt V, Rougemont J, Cole ST. Comparative genomics of Esx genes from clinical isolates of Mycobacterium tuberculosis provides evidence for gene conversion and epitope variation. Infect Immun (2011) 79:4042-9. doi:10.1128/IAI.05344-11
70. Jones GJ, Gordon SV, Hewinson RG, Vordermeier HM. Screening of predicted secreted antigens from Mycobacterium bovis reveals the immunodominance of the ESAT-6 protein family. Infect Immun (2010) 78:1326-32. doi:10.1128/IAI.01246-09
71. Chegou NN, Heyckendorf J, Walzl G, Lange C, Ruhwald M. Beyond the IFN-gamma horizon: biomarkers for immunodiagnosis of infection with M. tuberculosis. Eur Respir J (2013). doi:10.1183/09031936.00151413
72. Wilkinson RJ, Vordermeier HM, Wilkinson KA, Sjolund A, Moreno C, Pasvol G, et al. Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J Infect Dis (1998) 178:760-8. doi:10.1086/515336
73. Dieli F, Friscia G, Di Sano C, Ivanyi J, Singh M, Spallek R, et al. Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy. J Infect Dis (1999) 180:225-8. doi:10.1086/314852
74. Caccamo N, Dieli F. Are polyfunctional cells protective in M. tuberculosis infection? In: Cardona P-J, editor. Understanding Tuberculosis-Analyzing the Origin of Mycobacterium tuberculosis Pathogenicity. Rieka: InTech (2012). p. 313-42.
75. Goletti D, Carrara S, Mayanja-Kizza H, Baseke J, Mugerwa MA, Girardi E, et al. Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infect Dis (2008) 8:11. doi:10.1186/1471-2334-8-11
76. Geldmacher C, Ngwenyama N, Schuetz A, Petrovas C, Reither K, Heeregrave EJ, et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med (2010) 207:2869-81. doi:10.1084/jem.20100090
77. Singh SP, Mehra NK, Dingley HB, Pande JN, Vaidya MC. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J Infect Dis (1983) 148:676-81. doi:10.1093/infdis/148.4.676
78. Brahmajothi V, Pitchappan RM, Kakkanaiah VN, Sashidhar M, Rajaram K, Ramu S, et al. Association of pulmonary tuberculosis and HLA in south India. Tubercle (1991) 72:123-32. doi:10.1016/0041-3879(91)90039-U
79. Bothamley GH, Beck JS, Schreuder GM, D'Amaro J, de Vries RR, Kardjito T, et al. Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis (1989) 159:549-55. doi:10.1093/infdis/159.3.549
80. Ivanyi J, Thole J. Specificity and function of T and B cell recognition in tuberculosis. In: Bloom BR, editor. Tuberculosis: Pathogenesis, Protection and Control. Washington, DC: ASM Press (1994). p. 437-58.
81. Rossi-Bergmann B, Muller I, Godinho EB. TH1 and TH2 T-cell subsets are differentially activated by macrophages and B cells in murine leishmaniasis. Infect Immun (1993) 61:2266-9.
82. Pitchappan RM, Agrewala JN, Dheenadhayalan V, Ivanyi J. Major histocompatibility complex restriction in tuberculosis susceptibility. J Biosci (1997) 22:47-57. doi:10.1007/BF02703617
83. Brett S, Orrell JM, Swanson Beck J, Ivanyi J. Influence of H-2 genes on growth of Mycobacterium tuberculosis in the lungs of chronically infected mice. Immunology (1992) 76:129-32.
84. Ivanyi J, Sharp K. Control by H-2 genes of murine antibody responses to protein antigens of Mycobacterium tuberculosis. Immunology (1986) 59:329-32.
85. Barcenas-Morales G, Merkenschlager M, Wahid F, Doffinger R, Ivanyi J. Recessive expression of the H2A-controlled immune response phenotype depends critically on antigen dose. Immunology (2000) 99:221-8. doi:10.1046/j.1365-2567.2000.00956.x
86. Brett SJ, Ivanyi J. Genetic influences on the immune repertoire following tuberculous infection in mice. Immunology (1990) 71:113-9.
87. Orrell JM, Brett SJ, Ivanyi J, Coghill G, Grant A, Beck JS. Morphometric analysis of Mycobacterium tuberculosis infection in mice suggests a genetic influence on the generation of the granulomatous inflammatory response. J Pathol (1992) 166:77-82. doi:10.1002/path.1711660112
88. Verbon A, Hartskeerl RA, Moreno C, Kolk AH. Characterization of B cell epitopes on the 16K antigen of Mycobacterium tuberculosis. Clin Exp Immunol (1992) 89:395-401. doi:10.1111/j.1365-2249.1992.tb06969.x
89. Vordermeier HM, Harris DP, Moreno C, Singh M, Ivanyi J. The nature of the immunogen determines the specificity of antibodies and T cells to selected peptides of the 38 kDa mycobacterial antigen. Int Immunol (1995) 7:559-66. doi:10.1093/intimm/7.4.559
90. Harris DP, Hill M, Vordermeier HM, Jones M, Hewinson G, Thangaraj H, et al. Mutagenesis of an immunodominant T cell epitope can affect recognition of different T and B determinants within the same antigen. Mol Immunol (1997) 34:315-22. doi:10.1016/S0161-5890(97)00041-2
91. Zhu X, Stauss HJ, Ivanyi J, Vordermeier HM. Specificity of CD8+ T cells from subunit-vaccinated and infected H-2b mice recognizing the 38 kDa antigen of Mycobacterium tuberculosis. Int Immunol (1997) 9:1669-76. doi:10.1093/intimm/9.11.1669
92. Zhu X, Venkataprasad N, Thangaraj HS, Hill M, Singh M, Ivanyi J, et al. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J Immunol (1997) 158:5921-6.
93. Bennekov T, Dietrich J, Rosenkrands I, Stryhn A, Doherty TM, Andersen P. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis. Eur J Immunol (2006) 36:3346-55. doi:10.1002/eji.200636128
94. Tchilian E, Ahuja D, Hey A, Jiang S, Beverley P. Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy. Vaccine (2013) 31:4624-31. doi:10.1016/j.vaccine.2013.07.040
95. Suzuki D, Nagata T, Eweda G, Matsumoto S, Matsumoto M, Tsujimura K, et al. Characterization of murine T-cell epitopes on mycobacterial DNA-binding protein 1 (MDP1) using DNA vaccination. Vaccine (2010) 28:2020-5. doi:10.1016/j.vaccine.2009.10.062
96. Wang LX, Nagata T, Tsujimura K, Uchijima M, Seto S, Koide Y. Identification of HLA-DR4-restricted T-cell epitope on MPT51 protein, a major secreted protein derived from Mycobacterium tuberculosis using MPT51 overlapping peptides screening and DNA vaccination. Vaccine (2010) 28:2026-31. doi:10.1016/j.vaccine.2009.10.063
97. Uto T, Tsujimura K, Uchijima M, Seto S, Nagata T, Suda T, et al. A novel vaccine strategy to induce mycobacterial antigen-specific Th1 responses by utilizing the C-terminal domain of heat shock protein 70. FEMS Immunol Med Microbiol (2011) 61:189-96. doi:10.1111/j.1574-695X.2010.00762.x
98. Cox JH, Ivanyi J, Young DB, Lamb JR, Syred AD, Francis MJ. Orientation of epitopes influences the immunogenicity of synthetic peptide dimers. Eur J Immunol (1988) 18:2015-9. doi:10.1002/eji.1830181222
99. De Smet KA, Vordermeier HM, Ivanyi J. A versatile system for the production of recombinant chimeric peptides. J Immunol Methods (1994) 177:243-50. doi:10.1016/0022-1759(94)90162-7
100. Wilkinson KA, Vordermeier MH, Kajtar J, Jurcevic S, Wilkinson R, Ivanyi J, et al. Modulation of peptide specific T cell responses by non-native flanking regions. Mol Immunol (1997) 34:1237-46. doi:10.1016/S0161-5890(98)00009-1
101. Wilkinson KA, Hudecz F, Vordermeier HM, Ivanyi J, Wilkinson RJ. Enhancement of the T cell response to a mycobacterial peptide by conjugation to synthetic branched polypeptide. Eur J Immunol (1999) 29:2788-96. doi:10.1002/(SICI)1521-4141(199909)29:09<2788::AID-IMMU2788>3.0.CO;2-4
102. Gowthaman U, Singh V, Zeng W, Jain S, Siddiqui KF, Chodisetti SB, et al. Promiscuous peptide of 16 kDa antigen linked to Pam2Cys protects against Mycobacterium tuberculosis by evoking enduring memory T-cell response. J Infect Dis (2011) 204:1328-38. doi:10.1093/infdis/jir548
103. Hewitt J, Coates AR, Mitchison DA, Ivanyi J. The use of murine monoclonal antibodies without purification of antigen in the serodiagnosis of tuberculosis. J Immunol Methods (1982) 55:205-11. doi:10.1016/0022-1759(82)90032-1
104. Sinha S, Sengupta U, Ramu G, Ivanyi J. Serological survey of leprosy and control subjects by a monoclonal antibody-based immunoassay. Int J Lepr Other Mycobact Dis (1985) 53:33-8.
105. Bothamley GH, Rudd R, Festenstein F, Ivanyi J. Clinical value of the measurement of Mycobacterium tuberculosis specific antibody in pulmonary tuberculosis. Thorax (1992) 47:270-5. doi:10.1136/thx.47.4.270
106. Wilkins EG, Ivanyi J. Potential value of serology for diagnosis of extrapulmonary tuberculosis. Lancet (1990) 336:641-4. doi:10.1016/0140-6736(90)92144-7
107. Bothamley G, Batra H, Ramesh V, Chandramui A, Ivanyi J. Serodiagnostic value of the 19 kilodalton antigen of Mycobacterium tuberculosis in Indian patients. Eur J Clin Microbiol Infect Dis (1992) 11:912-5. doi:10.1007/BF01962372
108. Ivanyi J. Serodiagnosis of tuberculosis: due to shift track. Tuberculosis (Edinb) (1989) 92:31-7. doi:10.1016/j.tube.2011.09.001
109. Chandramuki A, Bothamley GH, Brennan PJ, Ivanyi J. Levels of antibody to defined antigens of Mycobacterium tuberculosis in tuberculous meningitis. J Clin Microbiol (1989) 27:821-5.
110. Ivanyi J. Could active case finding reduce the transmission of tuberculosis? The Lancet (2014) 383:1035-6. doi:10.1016/S0140-6736(14)60510-9
111. Gaseitsiwe S, Valentini D, Mahdavifar S, Magalhaes I, Hoft DF, Zerweck J, et al. Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing 61 proteins from M. tuberculosis. PLoS One (2008) 3:e3840. doi:10.1371/journal.pone.0003840
112. Balu S, Reljic R, Lewis MJ, Pleass RJ, McIntosh R, van Kooten C, et al. A novel human IgA monoclonal antibody protects against tuberculosis. J Immunol (2011) 186:3113-9. doi:10.4049/jimmunol.1003189
113. Buccheri S, Reljic R, Caccamo N, Meraviglia S, Ivanyi J, Salerno A, et al. Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy. Tuberculosis (Edinb) (2009) 89:91-4. doi:10.1016/j.tube.2008.09.001
114. Harris DP, Vordermeier HM, Arya A, Bogdan K, Moreno C, Ivanyi J. Immunogenicity of peptides for B cells is not impaired by overlapping T-cell epitope topology. Immunology (1996) 88:348-54. doi:10.1046/j.1365-2567.1996.d01-673.x
115. Engberg J, Krogsgaard M, Fugger L. Recombinant antibodies with the antigen-specific, MHC restricted specificity of T cells: novel reagents for basic and clinical investigations and immunotherapy. Immunotechnology (1999) 4:273-8.
116. Engberg J, Yenidunya AF, Clausen R, Jensen LB, Sorensen P, Kops P, et al. Human recombinant Fab antibodies with T-cell receptor-like specificities generated from phage display libraries. Methods Mol Biol (2003) 207:161-77.
117. Cohen CJ, Denkberg G, Lev A, Epel M, Reiter Y. Recombinant antibodies with MHC-restricted, peptide-specific, T-cell receptor-like specificity: new tools to study antigen presentation and TCR-peptide-MHC interactions. J Mol Recognit (2003) 16:324-32. doi:10.1002/jmr.640
118. Denkberg G, Reiter Y. Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation. Autoimmun Rev (2006) 5:252-7. doi:10.1016/j.autrev.2005.07.004
119. Liddy N, Molloy PE, Bennett AD, Boulter JM, Jakobsen BK, Li Y. Production of a soluble disulfide bond-linked TCR in the cytoplasm of Escherichia coli trxB gor mutants. Mol Biotechnol (2010) 45:140-9. doi:10.1007/s12033-010-9250-0
120. Michaeli Y, Denkberg G, Sinik K, Lantzy L, Chih-Sheng C, Beauverd C, et al. Expression hierarchy of T cell epitopes from melanoma differentiation antigens: unexpected high level presentation of tyrosinase-HLA-A2 Complexes revealed by peptide-specific, MHC-restricted, TCR-like antibodies. J Immunol (2009) 182:6328-41. doi:10.4049/jimmunol.0801898
121. Epel M, Carmi I, Soueid-Baumgarten S, Oh SK, Bera T, Pastan I, et al. Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies. Eur J Immunol (2008) 38:1706-20. doi:10.1002/eji.200737524
122. Klechevsky E, Gallegos M, Denkberg G, Palucka K, Banchereau J, Cohen C, et al. Antitumor activity of immunotoxins with T-cell receptor-like specificity against human melanoma xenografts. Cancer Res (2008) 68:6360-7. doi:10.1158/0008-5472.CAN-08-0928
123. Caccamo N, Milano S, Di Sano C, Cigna D, Ivanyi J, Krensky AM, et al. Identification of epitopes of Mycobacterium tuberculosis 16-kDa protein recognized by human leukocyte antigen-A*0201 CD8(+) T lymphocytes. J Infect Dis (2002) 186:991-8. doi:10.1086/344174
124. Geluk A, van Meijgaarden KE, Franken KL, Drijfhout JW, D'Souza S, Necker A, et al. Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans. J Immunol (2000) 165:6463-71.
125. Chang ST, Linderman JJ, Kirschner DE. Multiple mechanisms allow Mycobacterium tuberculosis to continuously inhibit MHC class II-mediated antigen presentation by macrophages. Proc Natl Acad Sci U S A (2005) 102:4530-5. doi:10.1073/pnas.0500362102
126. Dadaglio G, Nelson CA, Deck MB, Petzold SJ, Unanue ER. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity (1997) 6:727-38. doi:10.1016/S1074-7613(00)80448-3
127. Croft NP, Smith SA, Wong YC, Tan CT, Dudek NL I, Flesch E, et al. Kinetics of antigen expression and epitope presentation during virus infection. PLoS Pathog (2013) 9:e1003129. doi:10.1371/journal.ppat.1003129
128. Molloy A, Laochumroonvorapong P, Kaplan G. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J Exp Med (1994) 180:1499-509. doi:10.1084/jem.180.4.1499
129. Fratazzi C, Arbeit RD, Carini C, Balcewicz-Sablinska MK, Keane J, Kornfeld H, et al. Macrophage apoptosis in mycobacterial infections. J Leukoc Biol (1999) 66:763-4.
130. Matthey B, Engert A, Klimka A, Diehl V, Barth S. A new series of pET-derived vectors for high efficiency expression of Pseudomonas exotoxin-based fusion proteins. Gene (1999) 229:145-53. doi:10.1016/S0378-1119(99)00038-4
131. Dalken B, Giesubel U, Knauer SK, Wels WS. Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition. Cell Death Differ (2006) 13:576-85. doi:10.1038/sj.cdd.4401773
132. Kurschus FC, Kleinschmidt M, Fellows E, Dornmair K, Rudolph R, Lilie H, et al. Killing of target cells by redirected granzyme B in the absence of perforin. FEBS Lett (2004) 562:87-92. doi:10.1016/S0014-5793(04)00187-5
133. Dharap SS, Qiu B, Williams GC, Sinko P, Stein S, Minko T. Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Control Release (2003) 91:61-73. doi:10.1016/S0168-3659(03)00209-8
134. Moreau C, Cartron PF, Hunt A, Meflah K, Green DR, Evan G, et al. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins. J Biol Chem (2003) 278:19426-35. doi:10.1074/jbc.M209472200
135. Condos R, Raju B, Canova A, Zhao BY, Weiden M, Rom WN, et al. Recombinant gamma interferon stimulates signal transduction and gene expression in alveolar macrophages in vitro and in tuberculosis patients. Infect Immun (2003) 71:2058-64. doi:10.1128/IAI.71.4.2058-2064.2003
136. Cousens LP, Najafian N, Mingozzi F, Elyaman W, Mazer B, Moise L, et al. In vitro and in vivo studies of IgG-derived Treg epitopes (Tregitopes): a promising new tool for tolerance induction and treatment of autoimmunity. J Clin Immunol (2013) 33(Suppl 1):S43-9. doi:10.1007/s10875-012-9762-4
137. Cousens LP, Su Y, McClaine E, Li X, Terry F, Smith R, et al. Application of IgG-derived natural Treg epitopes (IgG Tregitopes) to antigen-specific tolerance induction in a murine model of type 1 diabetes. J Diabetes Res (2013) 2013:621693. doi:10.1155/2013/621693
138. Cousens LP, Tassone R, Mazer BD, Ramachandiran V, Scott DW, De Groot AS. Tregitope update: mechanism of action parallels IVIg. Autoimmun Rev (2013) 12:436-43. doi:10.1016/j.autrev.2012.08.017
139. Olivares N, Leon A, Lopez Y, Puig A, Cadiz A, Falero G, et al. The effect of the administration of human gamma globulins in a model of BCG infection in mice. Tuberculosis (Edinb) (2006) 86:268-72. doi:10.1016/j.tube.2006.01.006
140. Olivares N, Puig A, Aguilar D, Moya A, Cadiz A, Otero O, et al. Prophylactic effect of administration of human gamma globulins in a mouse model of tuberculosis. Tuberculosis (Edinb) (2009) 89:218-20. doi:10.1016/j.tube.2009.02.003
141. Hougardy JM, Place S, Hildebrand M, Drowart A, Debrie AS, Locht C, et al. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am J Respir Crit Care Med (2007) 176:409-16. doi:10.1164/rccm.200701-084OC
142. Boer MC, van Meijgaarden KE, Bastid J, Ottenhoff TH, Joosten SA. CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells. Eur J Immunol (2013) 43:1925-32. doi:10.1002/eji.201243286
143. Li L, Lao SH, Wu CY. Increased frequency of CD4(+)CD25(high) Treg cells inhibit BCG-specific induction of IFN-gamma by CD4(+) T cells from TB patients. Tuberculosis (Edinb) (2007) 87:526-34. doi:10.1016/j.tube.2007.07.004
144. Quinn KM, McHugh RS, Rich FJ, Goldsack LM, de Lisle GW, Buddle BM, et al. Inactivation of CD4+ CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load. Immunol Cell Biol (2006) 84:467-74. doi:10.1111/j.1440-1711.2006.01460.x
145. Quinn KM, Rich FJ, Goldsack LM, de Lisle GW, Buddle BM, Delahunt B, et al. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis. Eur J Immunol (2008) 38:695-705. doi:10.1002/eji.200737888